Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

16.7%

1 terminated out of 6 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed with results

Key Signals

1 with results75% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
P 1 (1)
P 4 (1)

Trial Status

Completed3
Unknown2
Terminated1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT02598609Not ApplicableCompleted

SEPREVEN: a Stepped-wedge Randomised Controlled Trial

NCT03109574Not ApplicableCompleted

Access in Dialysis for Better Outcomes in Patient Therapy

NCT02227329Phase 1TerminatedPrimary

Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition

NCT03222232Completed

Catheter Salvage in Intestinal Failure Patients

NCT02917135Unknown

Angel® Catheter Post Market Registry

NCT01948245Phase 4UnknownPrimary

Clinical Trial Comparing Catheter Lock Solutions TaurolockTMHep 100 and Heparin 100 IE/ml.

Showing all 6 trials

Research Network

Activity Timeline